MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q1
hinzugefügt 22.04.2025
Danaher Corporation Kurzfristige Verbindlichkeiten 2011-2025 | DHR
Kurzfristige Verbindlichkeiten Jährlich Danaher Corporation
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.8 B | 8.27 B | 8.39 B | 8.14 B | 7.4 B | 4.93 B | 4.84 B | 4.79 B | 6.87 B | 6.17 B | 5.4 B | 4.53 B | 4.21 B | 4.17 B |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 8.39 B | 4.17 B | 6.07 B |
Kurzfristige Verbindlichkeiten anderer Aktien in der Diagnostik & Forschung
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Akumin
AKU
|
169 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
66.6 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
372 M | $ 20.31 | -5.8 % | $ 221 M |  China |
 |
Co-Diagnostics
CODX
|
5.75 M | $ 0.23 | -4.17 % | $ 6.75 M | USA |
 |
Biocept
BIOC
|
5.51 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
39.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Castle Biosciences
CSTL
|
49.4 M | $ 39.2 | -0.49 % | $ 1.09 B | USA |
 |
DarioHealth Corp.
DRIO
|
12.5 M | $ 10.36 | 3.19 % | $ 294 M |  Israel |
 |
BioNano Genomics
BNGO
|
37.3 M | $ 1.51 | -0.9 % | $ 1.92 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
13.8 M | - | - | $ 562 M |  Britain |
 |
Exact Sciences Corporation
EXAS
|
732 M | $ 101.86 | 0.28 % | $ 18.9 B | USA |
 |
DexCom
DXCM
|
1.56 B | $ 67.65 | 0.12 % | $ 26.1 B | USA |
 |
Enzo Biochem
ENZ
|
24.8 M | - | -8.98 % | $ 14.8 K | USA |
 |
Fulgent Genetics
FLGT
|
72.9 M | $ 26.63 | -0.34 % | $ 805 M | USA |
 |
Global Cord Blood Corporation
CO
|
647 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
54.2 M | - | 1.08 % | $ 308 M | USA |
 |
DermTech
DMTK
|
13.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
1.27 B | - | - | $ 10.7 B | USA |
 |
CareDx, Inc
CDNA
|
78.1 M | $ 19.19 | -1.49 % | $ 1.03 B | USA |
 |
Celcuity
CELC
|
31.7 M | $ 101.0 | -1.22 % | $ 3.98 B | USA |
 |
Heska Corporation
HSKA
|
39.6 M | - | - | $ 1.31 B | USA |
 |
Anixa Biosciences
ANIX
|
2.5 M | $ 3.19 | -0.31 % | $ 102 K | USA |
 |
HTG Molecular Diagnostics
HTGM
|
8.27 M | - | -20.0 % | $ 1.06 M | USA |
 |
IQVIA Holdings
IQV
|
6.96 B | $ 227.26 | 0.15 % | $ 41.2 B | USA |
 |
Guardant Health
GH
|
226 M | $ 100.93 | -1.99 % | $ 12.4 B | USA |
 |
Aspira Women's Health
AWH
|
5.78 M | - | -6.19 % | $ 10.5 M | USA |
 |
Myriad Genetics
MYGN
|
164 M | $ 6.32 | -2.55 % | $ 573 M | USA |
 |
ENDRA Life Sciences
NDRA
|
605 K | $ 4.75 | -4.81 % | $ 2.55 M | USA |
 |
Neogen Corporation
NEOG
|
174 M | $ 7.2 | 0.98 % | $ 1.56 B | USA |
 |
National Research Corporation
NRC
|
36.2 M | $ 18.95 | 1.55 % | $ 465 M | USA |
 |
Illumina
ILMN
|
1.55 B | $ 134.56 | -0.29 % | $ 21.4 B | USA |
 |
Charles River Laboratories International
CRL
|
994 M | $ 203.33 | -0.11 % | $ 10.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
2.17 B | $ 175.36 | -0.34 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
14.3 M | $ 6.79 | -0.44 % | $ 880 M | USA |
 |
Motus GI Holdings
MOTS
|
3.27 M | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
3.33 B | $ 252.95 | -0.4 % | $ 21.2 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.8 B | $ 182.75 | -0.05 % | $ 15.1 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.07 B | $ 685.99 | -0.36 % | $ 56.6 B | USA |
 |
Lantheus Holdings
LNTH
|
241 M | $ 67.0 | 0.43 % | $ 4.64 B | USA |
 |
Personalis
PSNL
|
31.1 M | $ 8.01 | -1.6 % | $ 475 M | USA |
 |
Mettler-Toledo International
MTD
|
1.17 B | $ 1 419.41 | -0.06 % | $ 30.1 B |  Schweiz |
 |
Agilent Technologies
A
|
1.71 B | $ 138.09 | -0.22 % | $ 42 B | USA |
 |
Quidel Corporation
QDEL
|
337 M | $ 29.27 | -0.12 % | $ 1.23 B | USA |
 |
Biomerica
BMRA
|
1.74 M | $ 2.6 | -3.7 % | $ 5.97 M | USA |